Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
Study NCT ID:
NCT04384666
Status:
COMPLETED
Last Update Posted:
2020-10-14
First Post:
2020-05-08
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
Sponsor:
Luye Pharma Group Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-08
First Submit QC Date:
None
Study First Post Date:
2020-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-13
Last Update Post Date:
2020-10-14
Last Update Post Date Type:
ACTUAL